arrow
P

Patrick J. O'Connor

health partners institute
H指数:72
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trends in utilization of glucagon-like peptide‑1 receptor agonists, sodium–glucose cotransporter‑2 inhibitors, and metabolic bariatric surgery in U.S. Adults with diabetes and obesity

美国糖尿病和肥胖成人中胰高血糖素样肽-1受体激动剂、钠-葡萄糖共转运蛋白-2抑制剂和代谢减肥手术的使用趋势

2026-08-200
PRE
Reduction in End-of-life Care Anxiety in Family Caregivers of Individuals in Palliative Care: Results of a Pilot Exploratory Study Using a Canadian Virtual Reality Technology

临终关怀中家庭照护者焦虑的减少:一项使用加拿大虚拟现实技术的探索性试点研究结果

2026-01-010
OAAI
Exposure to clinical decision support and training increases primary care clinician confidence in managing cognitive impairment care but not confidence to diagnose

接触临床决策支持和培训能够增强初级保健临床医生在管理认知障碍护理方面的信心,但不能增强其在诊断方面的信心。

2025-11-180
OAAI
GLP-1RA comparative effectiveness against dementia onset relative to other antidiabetic medications in a large, multi-site cohort of patients with type 2 diabetes

GLP-1RA相对于其他抗糖尿病药物在大型多中心2型糖尿病患者队列中预防痴呆发生的比较有效性。

2025-09-150
OAAI
Prevalence of Cardiovascular Risk Factors in Pediatric Patients in a Large Rural Health System

大型农村医疗体系中儿科患者心血管风险因素的患病率

2024-11-120
PRE
Race and ethnicity and pharmacy dispensing of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes

2型糖尿病中SGLT2抑制剂和GLP-1受体激动剂的种族,种族和药房分配

2024-06-015
OAAI
Comparing Pharmacist-Led Telehealth Care and Clinic-Based Care for Uncontrolled High Blood Pressure: The Hyperlink 3 Pragmatic Cluster-Randomized Trial

比较由药剂师主导的远程医疗保健和基于临床的护理对不受控制的高血压的影响: Hyperlink 3实用集群随机试验

2022-12-0121
OA